Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Hikma Pharmaceuticals (HIK)

Price 1,695.00p on 27-01-2023 at 18:00:51
Change 39.50p 2.39%
Buy 1,687.00p
Sell 1,685.50p
Buy / Sell HIK Shares
Last Trade: Unknown 2,667.00 at 1,677.108p
Day's Volume: 388,106
Last Close: 1,695.00p
Open: 1,665.50p
ISIN: GB00B0LCW083
Day's Range 1,659.50p - 1,695.00p
52wk Range: 1,174.50p - 2,137.00p
Market Capitalisation: £3,733m
VWAP: 1,688.12514p
Shares in Issue: 220m

Recent Trades History Hikma Pharmaceuticals (HIK)

Buy/Sell Volume Trade Prc Trade Type Trade Time
Unknown* 2,667 1,677.108p Ordinary
Currency Conversion
OTC Trade
18:00:10 - 27-Jan-23
Unknown* 23 1,695.00p Ordinary
Currency Conversion
OTC Trade
17:59:18 - 27-Jan-23
Unknown* 1,793 1,695.00p Ordinary
Currency Conversion
OTC Trade
17:58:11 - 27-Jan-23
Unknown* 1,594 1,695.00p Ordinary
Currency Conversion
OTC Trade
17:58:11 - 27-Jan-23
Unknown* 10,173 1,679.291p Ordinary
Currency Conversion
OTC Trade
17:55:31 - 27-Jan-23
Unknown* 10,020 1,678.317p Ordinary
Currency Conversion
OTC Trade
17:55:19 - 27-Jan-23
Unknown* 6,413 1,693.146p Ordinary
Currency Conversion
OTC Trade
17:53:02 - 27-Jan-23
Unknown* 241 1,678.954p Ordinary
Currency Conversion
OTC Trade
17:51:26 - 27-Jan-23
Unknown* 362 1,694.975p Ordinary
Currency Conversion
OTC Trade
17:51:21 - 27-Jan-23
Unknown* 2,426 1,694.974p Ordinary
Currency Conversion
OTC Trade
17:51:06 - 27-Jan-23

Share Price History for Hikma Pharmaceuticals

Time period:
to
Date Open High Low Close Volume

Share News for Hikma Pharmaceuticals

LONDON BROKER RATINGS: Goldman likes UK banks; HSBC cuts Dr Martens

25th Jan 2023 09:33

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning: Read More

Arecor transfers AT307 drug to Hikma for development, regains AT282

12th Jan 2023 17:55

(Alliance News) - Arecor Therapeutics PLC on Thursday said it transferred development activities for the ready-to-use injectable medicine AT307 to Hikma Pharmaceuticals PLC, and regained rights on AT282 after a product portfolio review. Read More

Hikma launches version of Xyrem medicine in US for treating narcolepsy

3rd Jan 2023 09:25

(Alliance News) - Hikma Pharmaceuticals PLC on Tuesday said it launched an authorised generic version of the Xyrem sodium oxybate prescription medicine in the US for treating narcolepsy. Read More

LONDON BROKER RATINGS: Citigroup cuts Wizz Air; Redburn likes CRH

3rd Jan 2023 09:24

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning, Monday and late Friday: Read More

LONDON MARKET OPEN: Stocks jump in first session of 2023

3rd Jan 2023 09:03

(Alliance News) - Stock prices in London made a strong start to the new year on Tuesday, despite weak Chinese data and the UK suffering a fresh wave of rail strikes. Read More

FTSE 100 Latest
Value7,765.15
Change4.04

Login to your account

Forgot Password?

Not Registered